# Eco Polymer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eco-polymer

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.ecopolytec.com
- Latest round: Series C (Jan 8, 2026)
- Investors on record: 7

## About

Based in Shanghai, China and founded in 2009, Shanghai Eco Polymer Sci.&Tech. Co., Ltd., trading as Eco Polymer, is a medical device provider that focuses on the development and production of medical catheters and medical hollow fiber membranes. It has 8,000 square meters of purification plants in Taizhou and Shanghai Zhangjiang, with Taizhou plant covering 7,000 square meters, and the Shanghai plant covering 1,500 square meters. And it set up a 2,000 square meter technology research and development center in Shanghai Lingang. It also established branches in Suzhou and San Francisco. Moreover, its cooperation partners include Medtronic, WEGO, Boston Scientific, JABIL, and others. In January 2026, Eco Polymer closed Series C funding from returning investor Suzhou International Development Venture Capital Holding.

It provides catheters and membrane materials for medical devices. Catheter products include nerve and peripheral microcatheter, vascular catheter sheaths, vascular guiding catheters, balloon material tubes, spring sheaths, disposable endoscopic catheters, and so on. And these catheter products are also used in the medical fields, including gastroenterology, neurological intervention, vascular intervention?, cardiac intervention, ?urology, gynecology, and IVD. The membrane materials are used for dialyzers, extracorporeal membrane oxygenation (EMO), hemodialysis, and artificial lung.

The company generates revenue by doing R&D, and providing catheters and membrane materials and other related products.

The series C funding raised in January 2026 will be used to accelerate new product development, expand production capacity, and advance its overseas market expansion.

## Funding rounds

- Series C, Jan 8, 2026 — Suzhou International Development Venture Capital Holding
- Series B, Jan 16, 2023 — Qiming Venture Partners, Suzhou International Development Venture Capital Holding, New Alliance Capital, SDIC Unity Capital, Yinglian Health Industry Fund
- Series B, May 22, 2022 — Qiming Venture Partners
- Series A, Aug 23, 2021 — YuanBio Venture, Lanwan Venture Capital

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Lanwan Venture Capital (https://capitalatlas.ai/funds/lanwan-venture-capital) — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series B
- Suzhou International Development Venture Capital Holding (https://capitalatlas.ai/funds/suzhou-international-development-venture-capital-holding) — Series B, Series C
- New Alliance Capital (https://capitalatlas.ai/funds/new-alliance-capital) — Series B
- SDIC Unity Capital (https://capitalatlas.ai/funds/sdic-unity-capital) — Series B
- Yinglian Health Industry Fund — Series B